Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Inhibrx Biosciences, Inc. before investing.

In this article, we go over a few key elements for understanding Inhibrx Biosciences, Inc.’s stock price such as:

• Inhibrx Biosciences, Inc.’s current stock price and volume
• Why Inhibrx Biosciences, Inc.’s stock price changed recently
• Upgrades and downgrades for INBX from analysts
• INBX’s stock price momentum as measured by its relative strength

About Inhibrx Biosciences, Inc. (INBX)

Before we jump into Inhibrx Biosciences, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, which is in phase 1, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head non-small cell lung cancer cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.

Want to learn more about Inhibrx Biosciences, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Inhibrx Biosciences, Inc..

Inhibrx Biosciences, Inc.’s Stock Price as of Market Close

As of May 04, 2026, 11:58 AM, CST, Inhibrx Biosciences, Inc.’s stock price was $130.910.

Inhibrx Biosciences, Inc. is up 1.65% from its previous closing price of $128.780.

During the last market session, Inhibrx Biosciences, Inc.’s stock traded between $127.990 and $134.400. Currently, there are approximately 15.53 million shares outstanding for Inhibrx Biosciences, Inc..

Inhibrx Biosciences, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Inhibrx Biosciences, Inc. Stock Price History

Inhibrx Biosciences, Inc.’s (INBX) price is currently up 1.32% so far this month.

During the month of May, Inhibrx Biosciences, Inc.’s stock price has reached a high of $134.400 and a low of $124.752.

Over the last year, Inhibrx Biosciences, Inc. has hit prices as high as $155.290 and as low as $10.840. Year to date, Inhibrx Biosciences, Inc.’s stock is up 65.71%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Inhibrx Biosciences, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 01, 2026, there were 0 analysts who downgraded Inhibrx Biosciences, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Inhibrx Biosciences, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Inhibrx Biosciences, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Inhibrx Biosciences, Inc. (INBX) by visiting AAII Stock Evaluator.

Relative Price Strength of Inhibrx Biosciences, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 01, 2026, Inhibrx Biosciences, Inc. has a weighted four-quarter relative price strength of 78.89%, which translates to a Momentum Score of 99 and is considered to be Very Strong.

Want to learn more about how Inhibrx Biosciences, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Inhibrx Biosciences, Inc. Stock Price: Bottom Line

As of May 4, 2026, Inhibrx Biosciences, Inc.’s stock price is $130.910, which is up 1.65% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Inhibrx Biosciences, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.